Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0
Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
- Agency
- FDA Drug
- Recall date
- Jul 22, 2026
- Status
- Ongoing
- Company
- MICRO LABS USA INC
1. What product was recalled?
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.
Quantity: N/A
Code or lot text: Lot # DLHU0031, Exp Date: 06/30/2027.
- LOT
- Exp Date: 06/30/2027.
- LOT
- Lot # DLHU0031
- NDC
- 42571-147
- NDC
- 42571-147-26
- RECALL-NUMBER
- D-0730-2026
- UPC
- 0342571147266
2. Is my exact product affected?
Compare every printed identifier. A matching value can indicate that your product is included.
3. What is the hazard?
Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
4. What should I do now?
Follow the FDA recall notice and contact the recalling company for current instructions.
5. Where was it sold or distributed?
Nationwide
6. Were injuries or illnesses reported?
No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.
7. What remedy is available?
Follow the FDA recall notice and contact the recalling company for current instructions.
8. Is the recall active or closed?
The source status is Ongoing. Recall Index urgency is elevated, which is a separate deterministic site label.
9. When was the information checked?
Last checked .
- unchanged
- created
10. Where is the official source?
Open the official FDA Drug source
Recall Index normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.